jadenu

Generic: deferasirox

Labeler: novartis pharmaceuticals corporation
NDC Directory HUMAN PRESCRIPTION DRUG NDA Inactive Finished

Drug Facts

Product Profile

Brand Name jadenu
Generic Name deferasirox
Labeler novartis pharmaceuticals corporation
Dosage Form GRANULE
Routes
ORAL
Active Ingredients

deferasirox 180 mg/1

Manufacturer
Novartis Pharmaceuticals Corporation

Identifiers & Regulatory

Product NDC 0078-0713
Product ID 0078-0713_028e6158-3b78-41dd-99a8-6acb582f7245
Product Type HUMAN PRESCRIPTION DRUG
Marketing Category NDA
Application Number NDA207968
Listing Expiration 2026-12-31
Marketing Start 2017-05-18

Pharmacologic Class

Established (EPC)
iron chelator [epc]
Mechanism of Action
iron chelating activity [moa] cytochrome p450 3a4 inducers [moa] cytochrome p450 2c8 inhibitors [moa] cytochrome p450 1a2 inhibitors [moa]

Normalized Code Variants

Searchable formats for this product NDC code

Digits Only 00780713
Hyphenated Format 0078-0713

Supplemental Identifiers

RxCUI
1607784 1607790 1607792 1607794 1607796 1607798 1923822 1923825 1923826 1923827 1923828 1923829
UNII
V8G4MOF2V9
NUI
N0000000144 N0000175522 N0000185506 N0000187062 N0000182138

Packaging Origin

Original Packager
true

Resolved Product View

Precedence rule: structured NDC data is preferred, falling back to linked label metadata when unavailable. Source tags show the origin of each value.

Resolved Identity

Brand Name jadenu (source: ndc)
Generic Name deferasirox (source: ndc)
Application Number NDA207968 (source: ndc)
Routes
ORAL
source: ndc

Resolved Composition

Strengths
  • 180 mg/1
source: ndc
Packaging
  • 30 PACKET in 1 CARTON (0078-0713-15) / 1 GRANULE in 1 PACKET (0078-0713-19)
source: ndc

Packages (1)

0078-0713-15 30 PACKET in 1 CARTON (0078-0713-15) / 1 GRANULE in 1 PACKET (0078-0713-19)

Ingredients (1)

deferasirox (180 mg/1)

Linked Drug Pages (1)

Jadenu ndc-match (0.9)

Raw FDA Data

View complete raw FDA NDC JSON payload 
{"route": ["ORAL"], "spl_id": "028e6158-3b78-41dd-99a8-6acb582f7245", "openfda": {"nui": ["N0000000144", "N0000175522", "N0000185506", "N0000187062", "N0000182138"], "unii": ["V8G4MOF2V9"], "rxcui": ["1607784", "1607790", "1607792", "1607794", "1607796", "1607798", "1923822", "1923825", "1923826", "1923827", "1923828", "1923829"], "spl_set_id": ["fee89140-fff1-4443-9f42-24ac004fcda1"], "pharm_class_epc": ["Iron Chelator [EPC]"], "pharm_class_moa": ["Iron Chelating Activity [MoA]", "Cytochrome P450 3A4 Inducers [MoA]", "Cytochrome P450 2C8 Inhibitors [MoA]", "Cytochrome P450 1A2 Inhibitors [MoA]"], "manufacturer_name": ["Novartis Pharmaceuticals Corporation"], "is_original_packager": [true]}, "finished": true, "packaging": [{"sample": false, "description": "30 PACKET in 1 CARTON (0078-0713-15)  / 1 GRANULE in 1 PACKET (0078-0713-19)", "package_ndc": "0078-0713-15", "marketing_start_date": "20170518"}], "brand_name": "Jadenu", "product_id": "0078-0713_028e6158-3b78-41dd-99a8-6acb582f7245", "dosage_form": "GRANULE", "pharm_class": ["Cytochrome P450 1A2 Inhibitors [MoA]", "Cytochrome P450 2C8 Inhibitors [MoA]", "Cytochrome P450 3A4 Inducers [MoA]", "Iron Chelating Activity [MoA]", "Iron Chelator [EPC]"], "product_ndc": "0078-0713", "generic_name": "deferasirox", "labeler_name": "Novartis Pharmaceuticals Corporation", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "Jadenu", "active_ingredients": [{"name": "DEFERASIROX", "strength": "180 mg/1"}], "application_number": "NDA207968", "marketing_category": "NDA", "marketing_start_date": "20170518", "listing_expiration_date": "20261231"}